Suchergebnisse - "Cappello, Maria"

PubPharm (21)

1

Safety and effectiveness of tofacitinib in ulcerative colitis : Data from TOFA-UC, a SN-IBD study

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Macaluso, F. | D'Antonio, E. | Fries, W. | +17

2

Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission : The SVEDO Study, an IG-IBD study

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Ribaldone, D. | Parisio, L. | Variola, A. | +39

3

SARS-CoV-2 infection in patients with inflammatory bowel disease : comparison between the first and second pandemic waves

enthalten in: BMC gastroenterology | 2023

von Bezzio, C. | Vernero, M. | Costa, S. | +72

4

Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19

enthalten in: Inflammatory bowel diseases | 2023

von Macaluso, F. | Giuliano, A. | Fries, W. | +22

5

Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease : data from the Sicilian Network for Inflammatory Bowel Disease

enthalten in: European journal of gastroenterology & hepatology | 2022

von Dipasquale, V. | Pellegrino, S. | Ventimiglia, M. | +9

6

An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors

enthalten in: The American journal of gastroenterology | 2022

von Onali, S. | Pugliese, D. | Caprioli, F. | +28

7

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection : an IG-IBD study

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Bezzio, C. | Armuzzi, A. | Furfaro, F. | +69

8

SPOSAB ABP 501 : A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501

enthalten in: Journal of gastroenterology and hepatology | 2021

von Macaluso, F. | Cappello, M. | Busacca, A. | +23

9

Two-year effectiveness and safety of golimumab in ulcerative colitis : An IG-IBD study

enthalten in: United European gastroenterology journal | 2021

von Pugliese, D. | Privitera, G. | Rogai, F. | +29

10

The SPOSIB SB2 Sicilian Cohort : Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches

enthalten in: Inflammatory bowel diseases | 2021

von Macaluso, F. | Fries, W. | Viola, A. | +19